Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, Ltd., says that developing and marketing new drugs can be an arduous task. The many regulations that exist in most countries cost much time and money comply with. Small companies often don’t survive the startup phase because they become cash-depleted they are able to market any new products.
Sometimes, however, smaller startups create new treatments that are far more innovative than those manufactured by large corporations. Dr. Michael Har-Noy, has, with very limited resources, synthesized innovative new products that may change cancer treatment forever. These products will hopefully be brought to market in the near future.
Adjuvant therapy of cancer consists primarily of radiation and chemotherapy. These therapies are very toxic, resulting in devastating side effects and significantly worsening patients’ quality of life. Preliminary work done by Dr. Michael Har-Noy has demonstrated that immunologic treatments are much more effective than conventional ones and are far less toxic.
Currently, Dr. Michael Har-Noy is developing AlloStimTM, CryoStimTM, and AlloVaxTM, which are unique biologic compounds that “wake up” the body’s immune system and help it kill tumor cells. Initial results in of a Phase I/II study show significant efficacy of these drugs against many different cancers. Also, these proprietary compounds apparently have minimal toxic effect on the patient. Dr. Michael Har-Noy has received FDA approval in Thailand to undertake a randomized Phase II/III trial of AlloStimTM to treat metastatic colon cancer.
These unique drugs being created by Dr. Michael Har-Noy appear far more effective than traditional cancer treatments. They may create an entire new industry in the treatment of cancer.